Skip to content

Grants to Evidence for Healthcare Improvement

Amount Purpose Term Source
$7,500,000 To provide general operating support. 2021 - 2024 DAF
$21,666,892 To support the Institute for Clinical and Economic Review research that provides independent analyses of the comparative cost effectiveness for newly-introduced pharmaceutical drugs. 2017 - 2021 LJAF
$5,232,002 To produce Institute for Clinical and Economic Review reports on new drugs that include information about a drug's comparative effectiveness, cost effectiveness, and potential budget impact. 2015 - 2017 LJAF


Arnold Ventures funds projects to understand problems and identify policy solutions.